Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

282024-03

Constitutional Documents
282024-03

POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 28 MARCH 2024
152024-03

NOTICE OF BOARD MEETING
152024-03

PROFIT WARNING
082024-03

FORM OF PROXY FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON 28 MARCH 2024 OR AT ANY ADJOURNMENT THEREOF
082024-03

NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
082024-03

(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (2) NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
082024-03

PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
012024-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
012024-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
022024-01

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
012023-12

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

1 2 3 4 5

The Enterprise OA